Gliris-MP 2 Tablet SR
Marketer
Bioiris Pharmaceuticals Pvt Ltd
Salt Composition
Glibenclamide (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Gliris-MP 2 Tablet SR
Diabex Duo SR tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabex Duo SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is vital, even with well-controlled blood sugar, as discontinuation without medical supervision risks elevated glucose levels, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse reaction is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms—sweating, dizziness, headache, tremor—and appropriate countermeasures. Consistent meals and readily available fast-acting glucose sources (e.g., sugary foods, fruit juice) are crucial. Alcohol consumption increases hypoglycemia risk and should be minimized. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. Diabex Duo SR is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with potential blood tests to evaluate blood cell counts and liver function, are recommended.
Uses of Gliris-MP 2 Tablet SR
Managing type 2 diabetes
Major Benefits of Gliris-MP 2 Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Gliris-MP 2 Tablet SR whole; do not crush, chew, or break it. Administer this medication with a meal.
Common Side effects of Gliris-MP 2 Tablet SR:
- Anemia (low number of red blood cells)
- Hypoglycemia (low blood glucose level)
- Diarrhea
- Weight gain
- Headache
- Nausea
- Vomiting
- Blood in urine
- Erectile dysfunction
- Visual disorder
- Abdominal pain
How to use Gliris-MP 2 Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Gliris-MP 2 Tablet SR whole; avoid chewing, crushing, or breaking it. It should be taken with food.
How Gliris-MP 2 Tablet SR works:
Gliris-MP 2 SR tablets contain a triple-action antidiabetic formula: glibenclamide, metformin, and pioglitazone. These medications employ distinct methods to enhance blood glucose management when single or dual-drug regimens prove insufficient. Glibenclamide, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Gliris-MP 2 Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Gliris-MP 2 Tablet SR is contraindicated during pregnancy due to established fetal risk. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Extended-release Gliris-MP 2 tablets are contraindicated for breastfeeding mothers due to the potential for infant toxicity.
DrivingCONSULT YOUR DOCTOR
The effect of Gliris-MP 2 Tablet SR on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyUNSAFE
The use of Gliris-MP 2 Tablet SR is contraindicated in individuals with renal impairment and should be strictly avoided. Medical advice is recommended.
LiverCAUTION
Patients with hepatic impairment should use Gliris-MP 2 Tablet SR cautiously, potentially requiring dosage modification. Consult your physician. Gliris-MP 2 Tablet SR is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Gliris-MP 2 Tablet SR :
Should you forget a dose of Gliris-MP 2 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gliris-MP 2 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |


